Did you know…

In 1879, Moritz Kaposi was one of the first to observe lack of pigment granules in the rete pegs of vitiligo.1

0.1 – 2.0 % Global population effected by Vitiligo.2


% healed after 18 weeks

Patient story #1 – Vitiligo

There are limited options to treat hypopigmentation (where the skin has lost its normal colour) and vitiligo outside of a costly certified lab process or tedious grafting.

ReNovaCell™ treatment was used in a patient to reintroduce healthy cells of each of the various types found in normal skin (including melanocytes, responsible for producing the skin’s pigmentation or melanin) resulting in the restoration of normal pigmentation to a hypopigmented lesion associated with vitiligo.

Unlike other conventional therapies, ReNovaCell™ treatment is completed in a single procedure and does not require specialised equipment or a dedicated laboratory.

pigmentation_case-1_1  pigmentation_case-1_2

Photos courtesy of the Netherlands Institute for Pigment Disorders, Amsterdam


% restoration of normal pigmentation after 12 months

Patient story #2 – Burn scar

This patient with a hypopigmented scar had undergone three fraxel laser treatments to improve the aesthetic outcome, however the hypopigmentation persisted. Treatment with CO2 laser and RES™ restored almost 100% pigmentation in a single-stage procedure.

pigmentation_case-2_1  pigmentation_case-2_2

Photos courtesy of Associate Professor Greg Goodman, Dermatology Institute of Victoria, Australia

Fast healing and restoration of normal pigmentation and texture in acne scars


Patient story #3 – Flame burn scarring

In this case study, RES™ was used as part of the revision of a mature dyspigmented, hypertrophic flame burn scar.

The scar was successfully restored to near-normal colour through the introduction of multi-phenotype skin cells found in normal skin, allowing for the restoration of normal pigmentation.

At 12 months the skin was described as much improved and remained soft, allowing for a greater range of motion.

pigmentation_case-4_1  pigmentation_case-4_2

Photos courtesy of Winthrop Professor F. M. Wood Burns Service of Western Australia, Royal Perth Hospital, Australia.

ReNovaCell™ product video

  1. vitiligo and the melanocyte reservoir” by Rafael Falabella, M.D., Department of Dermatology, Universidad del Valle
  2. Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. “Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families.” Pigment Cell Research 16, no. 3 (2003): 208-214